LexDanaLexDanabeta
Inventor

ELLEN LAIRD

Inventor
US

Overview

2→
Patents
2022–2023
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%
C07DHeterocyclic compounds40%
A61KPreparations for medical, dental or toiletry purposes20%
PatentTitleYear
11,780,835Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases202311,247,990Bicyclic fused pyridine compounds as inhibitors of TAM kinases2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2023Patents assigned to ARRAY BIOPHARMA INC (2)· patent assignee history
2022–2023Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ARRAY BIOPHARMA INC22022–2023
Locations
LocationPatentsSpan
US22022–2023